TSX:CRONPharmaceuticals
Assessing Cronos Group (TSX:CRON) Valuation As Lord Jones Expands Into Israel
Why Cronos Group’s Israel Move Matters for Investors
Cronos Group (TSX:CRON) is extending its Lord Jones premium cannabis brand into Israel, introducing five indoor-grown flower strains to medical patients as part of a broader international expansion approach.
See our latest analysis for Cronos Group.
The Lord Jones launch in Israel comes as Cronos Group’s share price, at about CA$3.60, has seen a 1-year total shareholder return of 29.5% alongside a mixed pattern of shorter term share price...